Robert Hägerkvist

664 citations
9 papers · 538 indexed · h-index 8
Topics
Chronic Myeloid Leukemia Treatments (4 papers)PI3K/AKT/mTOR signaling in cancer (3 papers)Protein Kinase Regulation and GTPase Signaling (2 papers)

In The Last Decade

Robert Hägerkvist

9 papers receiving 525 citations

Peers

Robert Hägerkvist
Comparison fields: 5 of 62
  • Molecular Biology 337
  • Surgery 132
  • Hematology 110
  • Oncology 98
  • Immunology 95
Replace Enjing Jin with:
Enjing Jin Japan
Choong Chin Liew United States
Nicholas Bockett New Zealand
Brinda Alagesan United States
Megan Fuller Canada
Olubunmi Afonja United States
Maurizio Trubia Italy
Kazuhide Misawa Japan
Zahra Kadri France
Satoru Takahashi Japan
Robert Hägerkvist relative to Enjing Jin Japan Enjing Jin's profile →
Citations per field
00.5×1.5×2.3×
Enjing Jin · 1×
Citations per year

Countries citing papers authored by Robert Hägerkvist

Since Specialization
Citations

This map shows the geographic impact of Robert Hägerkvist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Hägerkvist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Hägerkvist more than expected).

Fields of papers citing papers by Robert Hägerkvist

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Hägerkvist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Hägerkvist. The network helps show where Robert Hägerkvist may publish in the future.

Co-authorship network of co-authors of Robert Hägerkvist

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Hägerkvist. A scholar is included among the top collaborators of Robert Hägerkvist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Hägerkvist. Robert Hägerkvist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1
[STRIDA in the fight against il(legal) Internet drugs].
1
2 49
3 46
4 16
5 113
6 22
7 205
8 14
9 72

About Robert Hägerkvist

Robert Hägerkvist is a scholar working on Hematology, Immunology and Allergy and Rheumatology, having authored 9 papers that have together received 538 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). The work is most often cited by research in Hematology (110 citations), Genetics (54 citations) and Molecular Biology (337 citations). Robert Hägerkvist has collaborated with scholars based in Sweden, United States and Germany. Frequent co-authors include Nils Welsh, Dariush Mokhtari, Michael Welsh, Stellan Sandler, Nader Rahimi, Lena Claesson‐Welsh, Charlotte Rolny, Tarô Matsumoto, Kristina Holmqvist and Michael Cross. Their work appears in journals such as Journal of Biological Chemistry, Diabetes and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026